Biologicals production by recombinant DNA technology in Cuba.
During 1981 we started an intensive programme for the development of biotechnology in Cuba. The first project was related to the production of leucocyte interferon and the cloning an expression of these genes in prokaryotic and yeast cells. These products are currently obtained in large amounts and their physical and chemical characterization are presented. The use of mammalian cells in culture for the production of recombinant proteins has also been carried out. The results obtained with the expression and amplification of the hepatitis B surface antigen (HBsAg) in CHO cells are discussed and compared with that obtained in yeast. The construction of a recombinant vaccinia virus carrying the HBsAg was also achieved. The specific transcripts were characterized and the Ab levels tested in animals. The results presented here indicate that the host system is a very important aspect to be taken into consideration and in some cases mammalian cells appear to be the best choice.
Herrera
L
L
Center for Genetic Engineering and Biotechnology, Havana, Cuba.
Del la Fuente
J
J
Quinones
Y
Y
Padron
G
G
Agraz
A
A
Vega
J
J
Perez
L
L
Silva
A
A
Santizo
C
C
Alvarez
R
R
D000818:Animals; D001688:Biological Products / Q000096:biosynthesis*; D001709:Biotechnology / Q000379:methods; D002460:Cell Line; D006224:Cricetinae; D003462:Cuba; D006514:Hepatitis B Surface Antigens / Q000235:genetics / Q000302:isolation & purification; D007370:Interferon Type I / Q000302:isolation & purification; D007371:Interferon-gamma / Q000302:isolation & purification; D011817:Rabbits; D011994:Recombinant Proteins / Q000096:biosynthesis*; D014616:Vaccinia virus / Q000235:genetics
D001688:Biological Products; D006514:Hepatitis B Surface Antigens; D007370:Interferon Type I; D011994:Recombinant Proteins; D007371:Interferon-gamma